NEW YORK(GenomeWeb) – Genomics England today announced that the National Institute for Health Research National Biosample Centre will store samples of rare diseases and cancer patients participating in the UK's 100,000 Genomes Project.
In addition to storing and processing biological samples, such as blood, tumor tissue, and saliva, the NIHR National Biosample Centre will conduct analyses, including DNA extraction, of the samples. The biosample center opened last month and is the UK's largest biosample facility, Genomics England said.
James Peach, managing director for the Genomics England main program, said in a statement that the agreement is a "huge milestone" for the 100,000 Genomes Project as it embarks on the main phase of sequencing. "The NIHR National Biosample Centre's robust infrastructure and latest technology will enable high-caliber research and new scientific insights," he said. "Ultimately, this will mean new diagnostics and treatments for the benefit of patients."